z-logo
Premium
Reassessing the effects of histone deacetylase inhibitors on hippocampal memory and cognitive aging
Author(s) -
Castellano James F.,
Fletcher Bonnie R.,
Patzke Holger,
Long Jeffrey M.,
Sewal Angila,
Kim David H.,
KelleyBell Bennett,
Rapp Peter R.
Publication year - 2014
Publication title -
hippocampus
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.767
H-Index - 155
eISSN - 1098-1063
pISSN - 1050-9631
DOI - 10.1002/hipo.22286
Subject(s) - sodium butyrate , hippocampal formation , acetylation , hippocampus , histone , epigenetics , histone deacetylase , neuroscience , memory impairment , histone deacetylase inhibitor , pharmacology , psychology , chemistry , medicine , cognition , biochemistry , gene
Converging results link histone acetylation dynamics to hippocampus‐dependent memory, including evidence that histone deacetylase inhibitor (HDACi) administration enhances long‐term memory. Previously, we demonstrated that aging disrupts the coordinated epigenetic response to recent experience observed in the young adult hippocampus. Here, we extended that work to test the cognitive effects of a novel, brain‐penetrant HDACi (EVX001688; EVX) that we confirmed yields robust, relatively long lasting dose‐dependent increases in histone acetylation in the hippocampus. In young rats, acute systemic EVX administration, scheduled to yield elevated histone acetylation levels during training in a contextual fear conditioning (CFC) task, had no effect on memory retention at 24 h at any dose examined (10, 30, or 60 mg/kg). Pretraining injection of another HDACi, sodium butyrate, also failed to affect fear memory, and CFC training itself had no influence on hippocampal histone acetylation at 1 hour in mice or two strains of rats. EVX administration before water maze training in young rats yielded a modest effect such that the middle dose produced marginally better 24‐h retention than either the low or high dose, but only a small numerical benefit relative to vehicle. Guided by those findings, a final experiment tested the influence of pretraining EVX treatment on age‐related spatial memory impairment. The results, revealing no effect on performance, are consistent with the idea that effective procognitive HDACi treatments in aging may require intervention aimed at restoring coordinated epigenetic regulation rather than bulk increases in hippocampal histone acetylation. © 2014 Wiley Periodicals, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here